Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy

doi:10.4251/wjgo.v16.i3.761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1197)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

911

Figures (1-4)

Tables (1-3)

Sum=1043

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=124

Mar 15, 2024 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Mar 15, 2024; 16(3): 761-772
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761

Full Size Figure Download Figure

Figure 3 Comparison of survival rates Barcelona clinic liver cancer stages. The blue line represents patients with Barcelona Clinic Liver Cancer (BCLC) 0 or A (early); the orange line represents patients with BCLC B (intermediate); and the green line represents patients with BCLC C or D (advanced).

Citation: Bracco C, Gallarate M, Badinella Martini M, Magnino C, D'Agnano S, Canta R, Racca G, Melchio R, Serraino C, Polla Mattiot V, Gollè G, Fenoglio L. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy. World J Gastrointest Oncol 2024; 16(3): 761-772
URL: https://www.wjgnet.com/1948-5204/full/v16/i3/761.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.761